TrialPloS one2015

No impact of vitamin D on the CYP3A biomarker 4β-hydroxycholesterol in patients with abnormal glucose regulation.

Buster Mannheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.